Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
|
|
Edesa Biotech, Inc. (SBOT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
8-K
| Quarterly results |
| 08/21/2023 |
SC 13D/A
| Pardeep Nijhawan Medicine Professional Corp reports a 20.9% stake in EDESA BIOTECH, INC. |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/04/2023 |
4
| Lemieux Stephen (CFO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 17,400 shares
@ $0 |
|
| 08/04/2023 |
4
| Brooks Michael J (President) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 93,200 shares
@ $0 |
|
| 08/04/2023 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 99,300 shares
@ $0 |
|
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
3
| Lemieux Stephen (CFO) has filed a Form 3 on Edesa Biotech, Inc. |
| 05/24/2023 |
3
| Olson Charles V (Director) has filed a Form 3 on Edesa Biotech, Inc. |
| 05/24/2023 |
3
| Chypyha Joan (Director) has filed a Form 3 on Edesa Biotech, Inc. |
| 05/24/2023 |
3
| Marshall Patrick (Director) has filed a Form 3 on Edesa Biotech, Inc. |
| 05/24/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/24/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
|
|
|